How to design a study to evaluate therapeutic drug monitoring in infectious diseases?-Reference-Cited by-同舟云学术

How to design a study to evaluate therapeutic drug monitoring in infectious diseases?

Published:2020-08 Issue:8 Volume:26 Page:1008-1016
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Märtson A.-G.,Sturkenboom M.G.G.,Stojanova J.,Cattaneo D.,Hope W.,Marriott D.,Patanwala A.E.,Peloquin C.A.,Wicha S.G.,van der Werf T.S.,Tängdén T.,Roberts J.A.,Neely M.N.,Alffenaar J.-W.C.

Funder

H2020 Marie Skłodowska-Curie Actions

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference88 articles.

1. What antibiotic exposures are required to suppress the emergence of resistance for Gram-negative bacteria? A systematic review;Sumi;Clin Pharmacokinet,2019

2. Clinical applications of population pharmacokinetic models of antibiotics: challenges and perspectives;de Velde;Pharmacol Res,2018

3. Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae?;Pea;Int J Antimicrob Agents,2017

4. Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients;Pea;J Antimicrob Chemother,2012

5. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients;Lodise;Clin Infect Dis,2009

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibiotic dose optimisation in the critically ill: targets, evidence and future strategies;Current Opinion in Critical Care;2024-07-05

2. Therapeutic Drug Monitoring and Biomarkers; towards Better Dosing of Antimicrobial Therapy;Pharmaceutics;2024-05-17

3. Therapeutic drug monitoring for isoniazid and rifampicin exposure;The International Journal of Tuberculosis and Lung Disease;2024-03-01

4. Salivary Therapeutic Drug Monitoring of Antimicrobial Therapy: Feasible or Futile?;Clinical Pharmacokinetics;2024-02-01

5. Standards for clinical trials for treating TB;The International Journal of Tuberculosis and Lung Disease;2023-12-01